Page last updated: 2024-10-23

bisbenzimidazole and Infarction, Middle Cerebral Artery

bisbenzimidazole has been researched along with Infarction, Middle Cerebral Artery in 2 studies

Bisbenzimidazole: A benzimidazole antifilarial agent; it is fluorescent when it binds to certain nucleotides in DNA, thus providing a tool for the study of DNA replication; it also interferes with mitosis.

Infarction, Middle Cerebral Artery: NECROSIS occurring in the MIDDLE CEREBRAL ARTERY distribution system which brings blood to the entire lateral aspects of each CEREBRAL HEMISPHERE. Clinical signs include impaired cognition; APHASIA; AGRAPHIA; weak and numbness in the face and arms, contralaterally or bilaterally depending on the infarction.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hu, Z1
Bian, X1
Liu, X1
Zhu, Y1
Zhang, X1
Chen, S1
Wang, K1
Wang, Y1
Unal Cevik, I1
Dalkara, T1

Other Studies

2 other studies available for bisbenzimidazole and Infarction, Middle Cerebral Artery

ArticleYear
Honokiol protects brain against ischemia-reperfusion injury in rats through disrupting PSD95-nNOS interaction.
    Brain research, 2013, Jan-23, Volume: 1491

    Topics: Animals; Biphenyl Compounds; Bisbenzimidazole; Blotting, Western; Cell Hypoxia; Cells, Cultured; Cen

2013
Intravenously administered propidium iodide labels necrotic cells in the intact mouse brain after injury.
    Cell death and differentiation, 2003, Volume: 10, Issue:8

    Topics: Animals; Apoptosis; Biomarkers; Bisbenzimidazole; Brain; Brain Injuries; Cell Death; Hypoxia-Ischemi

2003